# FDA Inspection 1228236 - RegenTX Partners LLC - January 23, 2024

Source: https://www.keypedia.com/records/fda_inspections/regentx-partners-llc/c95317a3-642a-40e6-bbe2-04b8f0d981c6
Source feed: FDA_Inspections

> FDA Inspection 1228236 for RegenTX Partners LLC on January 23, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1228236
- Company Name: RegenTX Partners LLC
- Inspection Date: 2024-01-23
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1284380 - 2025-10-17](https://www.keypedia.com/records/fda_inspections/regentx-partners-llc/be27757f-4c9e-4f84-b296-476ead3b9c6f)
- [FDA Inspection 1284380 - 2025-10-17](https://www.keypedia.com/records/fda_inspections/regentx-partners-llc/92aab561-b23b-43c8-9d30-b59ef3efbc21)
- [FDA Inspection 1113167 - 2019-11-15](https://www.keypedia.com/records/fda_inspections/regentx-partners-llc/afc93693-339d-45e9-85c0-5b929eb4f482)

Company: https://www.keypedia.com/companies/regentx-partners-llc/f392bf7b-b4a0-4737-8f61-01cc223ce55f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d